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Abstract By providing a source of α-smooth muscle actin
(α-SMA)-expressing myofibroblasts, microvascular peri-
cytes contribute to the matrix remodeling that occurs during
tissue repair. However, the extent to which pericytes may
contribute to the fibroblast phenotype post-repair is un-
known. In this report, we test whether pericytes isolated
from human placenta can in principle become fibroblast-
like. Pericytes were cultured in vitro for 11 passages. The
Affymetrix mRNA expression profile of passage 2 and
passage 11 pericytes was compared. The expression of type
I collagen, thrombospondin and fibronectin mRNAs was
induced by passaging pericytes in culture. This induction of
a fibroblast phenotype was paralleled by induction of
connective tissue growth factor (CTGF/CCN2) and type I
collagen protein expression and the fibroblast marker
ASO2. These results indicate that, in principle, pericytes
have the capacity to become fibroblast-like and that
pericytes may contribute to the population of fibroblasts
in a healed wound.
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Introduction
During tissue repair, fibroblasts migrate into the wound and
produce and remodel extracellular matrix (ECM). The
fibroblasts mediating this process are called myofibroblasts
as they express the highly contractile protein α-smooth
muscle actin (α-SMA) (Hinz and Gabbiani 2003). Al-
though the origin of the myofibroblasts during tissue repair
remains controversial, microvascular pericytes play a key
role in this process in skin, contributing to ~30% of the
myofibroblasts post-wounding (Rajkumar et al. 2006;
Abraham et al. 2007; Kapoor et al. 2008).
Pericytes begin migrating into the wound in a fashion
requiring signaling in response to platelet derived growth
factor (Rajkumar et al. 2006). Pericytes express α-SMA and
CTGF (Connective tissue growth factor/CCN2) and thus are
likelytocontributetothe migratoryand contractile phenotype
of myofibroblasts (Rajkumar et al. 2006; Kennedy et al.
2007;K a p o o re ta l .2008). However, the extent to which
pericytes may contribute to the overall characteristics of
tissue during and after wounding is unclear.
Pericytes passaged in cell culture increase their expres-
sion of prolyl-4-hydroxylase, type I procollagen, and
collagen pro-alpha1(I) mRNA, suggesting that pericytes
may develop into cells which highly express fibrotic
markers (Ivarsson et al. 1996). In this report, we use
Affymetrix gene profiling and Western blot analysis of
pericytes passaged in cell culture to assess the extent to
which pericytes may, in principle, become fibroblast-like.
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Materials and methods
Cell culture
Pericytes were isolated from human placenta and cultured as
previously described (Sundberg et al. 1996). Vascular frag-
ments of human term placenta were isolated by enzymatic
digestion and separation in Percoll, as previously described.
Their microvascular origin was ascertained by confocal
microscopy using antibodies specific for endothelial cells
(PAL-E) and pericytes (high-molecular-weight-melanoma-
associated antigen), as described. Cells were maintained in
Dulbecco’s modified Eagle’sm e d i u m( D M E M )( L i f eT e c h -
nologies, Grand Island, NY) supplemented with 10% fetal
bovine serum (Life Technologies), 100 U/ml penicillin, and
100 mg/ml streptomycin, and cultured in a humidified
atmosphere of 5% CO2, and were passaged 1:4. Phase
photography was taken on live cells using a Nikon
microscope and camera.
Western blot analysis
Cells were cultured until 80% confluence in DMEM 10%
FBS. Cells were cultured in DMEM, 0.5% FBS for an
additional 24 h to avoid the confounding effects of added
serum on protein expression. Cell layers were harvested
using 2% SDS. Proteins were quantified (Bradford, Bio-
Rad). Equal amounts of protein (25μg) were subjected to
SDS/PAGE using 4–12% polyacrylamide gels (Invitrogen).
Gels were blotted onto nitrocellulose, and proteins were
detected using anti-CCN2, anti-GAPDH (Santa Cruz), anti-
type I collagen (Biodesign), anti-ASO2 or α-SMA (Sigma)
antibodies followed by an appropriate HRP-conjugated
secondary antibody (Jackson Immunoresearch). Proteins
were detected using an enhanced chemiluminescence kit
(Amersham).
RNA quality assessment, probe preparation and gene chip
hybridization and analysis
Microarrays and analysis using human U133A v2.0 chips
were performed essentially as previously described (Chen
et al. 2005; Renzoni et al. 2004) by Imperial College,
London. RNA was harvested (Trizol, Invitrogen) and
quantified spectrophometrically. Biotinylated complimenta-
ry RNA (cRNA) was prepared from 10µg of total RNA as
per the Affymetrix GeneChip Technical Analysis Manual
(Affymetrix, Santa Clara, CA). Double-stranded cDNA was
synthesized using SuperScript II (Invitrogen, Carlsbad, CA)
and oligo(dT) 24 primers. Biotin-labeled cRNA was
prepared by using the Bizarre High-Yield RNA Transcript
Labeling kit (Enzo Brioche, New York, NY). Fifteen µg of
labeled cRNA was hybridized to Human Gene Chips and
were processed as described in the Affymetrix Technical
Analysis Manual (Affymetrix, Santa Clara, CA). Gene
Chips were scanned with the Affymetrix GeneChip Scanner
3000 (Affymetrix, Santa Clara, CA). Signal intensities for
genes were generated using GCOS1.2 (Affymetrix) using
default values for the Statistical Expression algorithm
parameters and a Target Signal of 150 for all probe sets
and a Normalization Value of 1. Normalization (per chip to
the 50th percentile, and per gene to baseline control) was
performed in GeneSpring 7.2 (Agilent Technologies Inc.,
Palo Alto, CA). Experiments were performed twice, and
Table 1 Affymetrix Gene expression profiling of pericytes at passage
2 and passage 11
Gene name Accession Number Fold change
Col1A1 Y15916 27.84
GREM1 (Gremlin) NM 013372 9.34
THBS1(Thrombospondin-1) AI812030 8.07
FN1 (Fibronectin 1) AJ276395 6.91
PDGF-D NM 0025208 5.22
MMP7 NM 002423 5.18
IL-8 AF043337 4.21
SDC1 (Syndecan 1) NM 002997 3.64
VEGF AF091352 3.63
ACTB (Actin beta) 3.49
MMP14 ZA4981 2.98
BMP1 NM 001199 2.66
Messages induced greater than 2.5-fold at passage 11 are shown
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Fig. 1 Induction of CCN2, type I collagen and ASO2 protein
production in pericytes passaged in vitro. Protein harvested from
primary human placenta pericyes in culture for 2, 3, 4, 5, 6, 7,11
passages post-isolation (P2, P3, P4, P5, P6, P7 and P11, respectively)
were subjected to Western blot analysis with anti-CCN2, anti-ASO2,
anti-type I collagen, anti-α-SMA and anti-GAPDH antibodies are
shown. Four different isolates of pericytes were tested. Westerns of
protein extracts from human dermal fibroblasts from two different
individuals are shown (F1 and F2)
62 X. Shiwen et al.fold changes were identified using the GeneSpring filter.
Messages induced greater than 2.5-fold were selected.
Results
Passaging of pericytes induces a fibroblast-like phenotype
To determine whether placenta perictyes could become
fibroblast-like, we passaged pericytes for 11 passages (with
a 1:4 split per passage) on plastic. RNAs were extracted
from cells at passage 2 and passage 11 and subjected to
Affymetrix genome-wide profiling. Table 1 illustrates that
genes involved with ECM and ECM remodeling were
induced greater than 2.5 fold. These mRNAs included type
I collagen, as expected (Ivarsson et al. 1996), thrombo-
spondin, fibronectin and several matrix metalloprotenases
(Table 1). Moreover, the angiogenic factor vascular endo-
thelial growth factor, which is involved with tissue
remodeling and repair, was also induced (Tonnesen et al.
2000). Western blot analysis confirmed that type I collagen
was induced by passaging (Fig. 1). Moreover, CCN2
(Leask and Abraham 2006) and the fibroblast marker
ASO2 (Saalbach et al. 1996) were also induced by
passaging pericytes in culture (Fig. 1). Pericytes also
acquired a fibroblast-like morphology (Fig. 2). These
results suggest that pericytes, in addition to contributing
to the α-SMA-expressing contractile myofibroblasts during
cutaneous wounding (Rajkumar et al. 2006; Kapoor et al.
2008; Fig. 1), may also contribute to the ECM production
by fibroblasts during and after wounding.
Discussion
Microvascular pericytes contribute comprise about 1/3 of
the total number of myofibroblasts in wound tissue
(Rajkumar et al. 2006; Kapoor et al. 2008). Pericytes
express α-SMA (Rajkumar et al. 2006; Kapoor et al. 2008)
and thus are likely to contribute to ECM contraction during
the wound healing process. Moreover, cell culture passaged
pericytes begin to express elevated levels of type I collagen
mRNA and protein (Ivarsson et al. 1996). In this report, we
were able to show that Affymetrix mRNA expression
profiling of pericytes passaged extensively in culture
revealed that pericytes can become fibroblast like, by
expressing an mRNA profile consistent with an ECM
remodeling phenotype. Cell-culture passaged pericytes also
responded by elevating CCN2 protein production, support-
ing the hypothesis that CCN2 expression is a faithful
marker of fibroblast activation (Leask et al. 2009). This
alteration in protein expression profile was paralleled by the
induction of ASO2 (CD90) protein, a fibroblast-specific
marker (Saalbach et al. 1996). These results collectively
enhance the notion that pericytes may be a source of
fibroblasts in vivo. Please note that although it is possible
that cell culture conditions may have selected for myofi-
broblasts, the change in cell morphology upon passaging
argues against this interpretation. Further studies (for
example a three dimensional cell culture system) may
permit a greater evaluation of the extent to which pericytes
may contribute to matrix production and remodeling.
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